No profile data available.
Zura Bio Limited (ZURA) is a healthcare company in the autoimmune treatment pharmaceuticals industry, based in Henderson, United States, with about 40 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$99.35 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $383.32 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States.
Zura Bio reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$383.32 million as of October 9, 2026.
Listed companies of a similar size in the same industry (autoimmune treatment pharmaceuticals) include Climb Bio Inc (CLYM), Shattuck Labs, Inc. (STTK), Kyverna Therapeutics, Inc. (KYTX), Cabaletta Bio, Inc. (CABA).